Galanis E, Anderson SK, Twohy EL, Carrero XW, et al. A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872. Cancer 2019 Jul 10. doi: 10.1002/cncr.32340.
PMID: 31290996